SACRIPANTI, GINEVRA
 Distribuzione geografica
Continente #
EU - Europa 313
NA - Nord America 306
AS - Asia 79
AF - Africa 20
OC - Oceania 6
SA - Sud America 2
Totale 726
Nazione #
US - Stati Uniti d'America 297
IT - Italia 160
SE - Svezia 71
DE - Germania 37
CN - Cina 35
SG - Singapore 20
BG - Bulgaria 19
CI - Costa d'Avorio 18
IN - India 9
VN - Vietnam 9
CA - Canada 8
NL - Olanda 7
AU - Australia 6
DK - Danimarca 5
HK - Hong Kong 4
PT - Portogallo 3
UA - Ucraina 3
BR - Brasile 2
CZ - Repubblica Ceca 2
FR - Francia 2
GB - Regno Unito 2
DM - Dominica 1
IR - Iran 1
KR - Corea 1
NG - Nigeria 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 726
Città #
Chandler 50
Serra 38
Milan 34
Frankfurt am Main 19
Sofia 19
Abidjan 18
New York 18
Houston 16
Wilmington 16
Ashburn 14
Beijing 14
Fairfield 14
Seattle 11
Florence 10
Princeton 10
Woodbridge 10
Cambridge 9
Bremen 8
Lawrence 8
Pisa 8
Rome 8
Medford 7
Singapore 7
Dong Ket 6
Hobart 6
Ottawa 6
Pune 6
Ann Arbor 5
Dearborn 4
Des Moines 4
Guiyang 4
Rødovre 4
Baleia 3
Norwalk 3
Redwood City 3
Bracciano 2
Central District 2
Cerro Maggiore 2
Charleston 2
Hong Kong 2
Jacksonville 2
Madison 2
Mestrino 2
Nanjing 2
Ogden 2
Pietrasanta 2
Portland 2
San Francisco 2
Shenzhen 2
Thrissur 2
Torino 2
Toronto 2
Xian 2
Abano Terme 1
Amsterdam 1
Avezzano 1
Berlin 1
Boardman 1
Brno 1
Brooklyn 1
Changsha 1
Chengdu 1
Chennai 1
Chicago 1
Cumming 1
Dakar 1
Denton 1
Falls Church 1
Guangzhou 1
Horia 1
Indiana 1
Ivry-sur-Seine 1
Kilburn 1
Kish 1
Lagos 1
Livorno 1
Los Angeles 1
Lucca 1
Marsala 1
Mountain View 1
Nanchang 1
Naples 1
Norcross 1
Olomouc 1
Roseau 1
San Antonio 1
San Diego 1
Sesto Fiorentino 1
Seveso 1
Shenyang 1
Siena 1
Social Circle 1
Stockholm 1
Tamm 1
Tappahannock 1
Udine 1
Totale 499
Nome #
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 133
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 120
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart 101
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 87
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. 78
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 76
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue 66
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 66
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1) 26
Totale 753
Categoria #
all - tutte 2.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202098 10 3 12 2 4 8 8 16 8 13 12 2
2020/202176 2 5 12 2 7 15 1 10 8 2 1 11
2021/2022101 2 4 0 2 20 14 2 4 8 4 16 25
2022/2023208 31 32 14 16 7 21 0 15 52 1 15 4
2023/2024133 12 14 20 12 16 25 3 5 6 2 10 8
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 753